Abstract: Migraine is a common disease with a high morbidity. Valproate (VP) is used as an anti-epilepsy drug in clinic. This study aimed to investigate the role of VP in nitroglycerin (NTG)-induced migraine using a mouse model. NTG was employed by intraperitoneal injection to induce a migraine model in mice. The NTG administration caused mouse head discomforts, decreased tolerance to cold or hot stimulation and increased content of nitric oxide, calcitonin gene-related peptide and neuropeptide Y in serum, which were ameliorated by intraperitoneal injection of VP. The levels of two inflammatory factors, interleukin (IL)-1b and inducible nitric oxide synthase, in dura mater were increased by NTG treatment, while the increase was attenuated by application of VP. In addition, the phosphorylation levels of protein kinase C (PKC) a, c, d and e were increased by NTG and decreased by VP. However, their total expression at the transcriptional and translational levels did not change significantly. Two substrates of PKC, cAMP-response element binding protein 1 and signal transducer and activator of transcription 1 were also phosphorylated by NTG application, and the phosphorylation level was attenuated by VP, consistent with the change of PKC informs. Together, we demonstrated that VP prevented damage due to migraine by inhibiting PKC signalling in NTGinjected mice, which may provide a basis for investigating the clinical treatment of migraine.
Migraine is the most common primary headache, with a prevalence of 10% in the general population [1] . Migraine is a recurrent neurological disorder characterized by throbbing headache, often accompanied by nausea, vomiting, visual disturbances, abnormal blood pressure and cardiac dysfunction.
Migraine is a refractory disease with incompletely understood pathogenesis. Various hypotheses have been put forward to explain the mechanism of migraine, including cortical spreading depression, trigeminal activation and sensitization, 5-hydroxytryptamine-induced vasoconstriction, cerebral oxidative stress response and inflammation [2] . Migraine is also seen with heritability estimates as high as 50% and with a likely polygenic multifactorial inheritance [3] . Several genes have been identified associated with familial migraine, such as LRP1, TRPM8 and KCNK18 [4] [5] [6] .
It has been reported that nitric oxide plays a significant role in nociceptive processing in the nervous system, including migraine [1, 7] . The pain sensitization in the spinal cord is associated with the generation of nitric oxide [8] . As a classic nitric oxide donor, nitroglycerin (NTG) could induce migraine-like headache [9, 10] . NTG infusion leads to a migraine attack in migraineurs with a latency of 4-6 hr [11] , and nitric oxide synthase (NOS) inhibitor has an antimigraine effect [12] . Reuter et al. [13] demonstrated that NTG administration promotes the expression of pro-inflammatory genes, and subsequent inflammatory reaction in the dura mater of rats, such as inducible NOS (iNOS). Thus, many investigators have used NTG-induced migraine animal models to study migraine [14, 15] .
At present, a large amount of drugs are used to prevent or treat migraine. Valproate (VP) has been proved effective for migraine prevention [16] and used as an anti-epilepsy seizure drug for more than a century. Moreover, it is also used for treatment of stroke, amyotrophic lateral sclerosis, Parkinson's disease and Alzheimer's disease [17] [18] [19] [20] . Recently, it has been reported that VP ameliorates migraine in animal models [15, 21] , and the US Food and Drug Administration (FDA) has approved VP for migraine prevention [22] . In this study, we employed NTG to induce a mouse migraine model via intraperitoneal injection and investigated the effect of VP on NTG-induced migraine in mice.
Materials and Methods
Ethical statement. The animals in this work were taken care of and treated according to Guide for the Care and Use of Laboratory Animals and the Lab Animals Care Guidelines of Harbin Medical University. The animal experiment was approved by the Ethics Committee of Harbin Medical University.
Animal model. Healthy male C57 mice (18-20 g ) were randomly divided into four groups: control, NTG, NTG+VP(L) and NTG+VP (H) (n = 6 per group). The mice in NTG+VP(L) and NTG+VP(H) groups were injected intraperitoneally with 100 ll VP of 100 mg/kg or 200 mg/kg daily for 5 days [21] , and the mice in the control and NTG groups were injected with the same volume of saline. At the sixth day, the mice in NTG, NTG+VP(L) and NTG+VP(H) groups were injected intraperitoneally with 100 ll NTG of 10 mg/kg, and the sham-operated mice were injected with the same volume of saline.
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At 4 hr post-injection of NTG, the head movement times of each mouse within 30 min. were recorded [21] . Each mouse was counted by two investigators, and the data were averaged. Thereafter, the blood of mice in each group was collected after eyeball enucleation. The mice were killed, and the dura mater was obtained for the subsequent experiments.
Another batch of mice were induced migraine by NTG and treated with VP according to the above description (n = 16 per group). At 0, 1, 2, 4 and 6 hr after injection of NTG, the mice of each group were placed on cold plates of 4°C or hot plates of 50°C, and the time length before mouse leg lift was counted as the reaction time on the cold or hot plate.
Nitric oxide content detection. The nitric oxide content in serum was detected using a NO Assay Kit (Jiancheng, Nanjing, Jiangsu, China) according to the manufacturer's protocol.
Serum of 100 ll was mixed with 200 ll buffer I and 100 ll buffer II and centrifuged at 1660 9 g for 15 min. The supernatant was collected and incubated with chromogenic agent for 15 min. The optical density (OD) of the solution was measured at 550 nm, with distilled water as the negative control and sodium nitrite of 20 lM as the positive control. The nitric oxide content (lM) = (OD 550 of sample À OD 550 of negative control)/(OD 550 of sample À OD 550 of negative control) 9 concentration of sodium nitrite (20 lM) 9 4.
ELISA. The content of calcitonin gene-related peptide (CGRP) or neuropeptide Y (NPY) in serum was detected using a CGRP ELISA Kit or an ELISA Kit for NPY (WHB, Shanghai, China) according to the manufacturer's protocols.
Calcitonin gene-related peptide standards (30, 20, 10, 5, 2.5 ng/l) of 50 ll were added into the ELISA plate and incubated at 37°C for 30 min. After washing five times with the washing buffer, the ELISA plate was incubated with conjugate reagent (50 ll per well) at 37°C for 30 min., washed with washing buffer and reacted with chromogenic reagent A (50 ll per well) and B (50 ll per well) at 37°C for 15 min. Finally, the determination buffer was added (50 ll each well) to terminate the reaction, and the OD of the solution was detected with a microplate reader at 450 nm. A blank group was treated with above operation without CGRP standard or conjugated reagent; the OD 450 was detected as the control. Subsequently, a CGRP standard curve was drawn with the CGRP standard concentration as the x-axis, and (OD 450 of CGRP standard À OD 450 of the control) as the y-axis. The serum sample was treated in the same way, and the CGRP content in the serum sample was calculated according to the CGRP standard curve.
Neuropeptide Y standard (360, 240, 120, 60, 30 ng/l) of 50 ll was added into the ELISA plate and treated according to the operation of CGRP standard. A NPY standard curve was drawn with the NPY standard concentration as the x-axis and (OD 450 of NPY standard À OD 450 of the control) as the y-axis. The NPY content in the serum was calculated according to the NPY standard curve.
Real-time PCR. Total RNA was extracted from the dura mater using a Total RNA Rapid Extraction Kit (BioTeke, Beijing, China) and reversely transcribed into cDNA by M-MLV super reverse transcriptase (BioTeke), with the presence of Oligo(dT) and random primers. The cDNA was used for real-time PCR using 29 Power Taq PCR Master Mix and SYBR Green to detect the mRNA levels of interleukin (IL)-1b, iNOS, protein kinase C (PKC)a, PKCc, PKCd, PKCe, cAMP-response element binding protein (CREB)1 and signal transducer and activator of transcription (STAT)1. The PCR procedure was set as follows: 95°C for 10 min., 40 cycles of 95°C for 10 sec., 60°C for 20 sec. and 72°C for 30 sec., and finally 4°C for 5 min. The PCR results were calculated according to the 2 ÀDDCt method. The primers were purchased from Sangon (Shanghai, China), and the sequences of real-time primers are shown in Table 1 .
Western blot. The protein was extracted from dura mater using RIPA buffer (Beyotime, Haimen, Jiangsu, China) supplemented with 1% PMSF (Beyotime) and denatured by 5-min. boiling. After measurement of concentration, the protein was separated with SDS-PAGE and transferred onto PVDF membrane (Millipore, Boston, MA, USA). After blocking with 5% skim milk (YILI, Hohhot, Inner Mongolia, China), the PVDF membrane was incubated with one of the following antibodies at 4°C overnight: rabbit anti-IL-1b (1:500; Sangon), rabbit anti-iNOS (1:400; Boster, Wuhan, Hubei, China), rabbit anti-PKCa (1:500; Sangon), rabbit anti-p-PKCa (1:1000; Abcam, Cambridge, UK), rabbit anti-PKCc (1:1000; CST, Boston, MA, USA), rabbit anti-p-PKCc (1:500; CST), rabbit anti-PKCd (1:500; Sangon), rabbit anti-p-PKCd (1:500; CST), rabbit anti-PKCe (1:1000; Abcam), rabbit anti-pPKCe (1:1000; Abcam), rabbit anti-CREB1 (1:1000; CST), rabbit anti-p-CREB1 (1:500; CST), rabbit anti-STAT1 (1:500; Sangon) and rabbit anti-STAT1 (1:500; Sangon). After rinsing with TrisHCl buffered saline Tween (TBST) the PVDF membrane was incubated with the corresponding HRP-conjugated secondary antibodies at 37°C for 45 min. and followed with a signal exposure using ECL reagent (Beyotime). After removing the antibodies with stripping buffer (Beyotime), the PVDF membrane was re-blotted with anti-b-actin (1:1000; Santa Cruz, CA, USA) and the secondary antibody (Beyotime). b-actin served as the endogenous control. The OD of bands was analysed by Gel-ProAnalyzer software (Media Cybernetics, Silver Spring, MD, USA).
Statistical analysis. 
IL-1b, interleukin-1b; iNOS, inducible nitric oxide synthase; PKC, protein kinase C; CREB1, cAMP-response element binding protein 1; STAT1, signal transducer and activator of transcription 1; F, forward; R, reverse.
Results
Valproate prevented NTG-induced migraine in a mouse model. Nitroglycerin was used to induce migraine in mice by intraperitoneal injection according to the description of Bates [23] . At 4 hr post-NTG administration, the head movement times of each mouse in 30 min. were recorded. As shown in fig. 1A , the mice in the control group had no head movement, while the mice injected with NTG showed frequent head movements, including head shaking and scratching with paws. However, the application of VP reduced the mice head movement times by 14% and 39% ( fig. 1A) . Data from the cold or hot plate test showed that the application of NTG reduced the reaction time length of mouse response to cold or hot stimulation, especially 4 hr after NTG injection; however, the decreased pain threshold was restored by VP to some degree ( fig. 1B,C) . Then, the nitric oxide content in serum was detected to be increased after application of NTG; however, the increase was attenuated by the injection of VP (Table 2) . Subsequently, the levels of two migraine-related peptides, CGRP and NPY, in serum were detected by ELISA. The results revealed that CGRP and NPY contents were increased 2.14-fold and 1.55-fold after the NTG treatment, while decreased by 35% and 27% after the VP application, respectively (Table 2) .
Valproate reduced NTG-induced inflammation in dura mater. Afterwards, the inflammation in dura mater of mice in each group was detected. The results revealed that the mRNA levels of IL-1b and iNOS were increased 6.08-fold and 5.32-fold after NTG injection ( fig. 2A) . The Western blot results showed similar increase in IL-1b and iNOS at protein level ( fig. 2B,C) , whereas the elevation of IL-b and iNOS levels was mitigated to some degree by treatment of VP ( fig. 2A-C) . In addition, iNOS is a key enzyme for nitric oxide synthesis. The results suggested that the injection of NTG induced endogenous nitric oxide production.
Valproate inhibited NTG-induced PKC phosphorylation.
The expression levels of PKC isoforms, PKCa, c, d and e were detected by real-time PCR and Western blot. The results revealed that the mRNA and total protein levels of PKC isoforms did not change significantly after application of NTG or VP ( fig. 3A,B) . Nevertheless, phosphorylation levels of PKCa, c, d and e in dura mater were increased 4.4-fold, 2.88-fold, 5.21-fold and 6.43-fold, respectively, after NTG administration ( fig. 3B,C) . However, the increased phosphorylation of PKC isoforms was attenuated by the intraperitoneal injection of VP ( fig. 3B,C) , suggesting that the activity of PKC isoforms was enhanced by NTG, but inhibited by VP.
Valproate inhibited NTG-induced PKC substrates activation. Subsequently, the results from Western blot showed that two PKC substrates, CREB1 and STAT1, were phosphorylated dramatically after administration of NTG; however, the phosphorylation was mitigated by VP treatment ( fig. 4C,D) . In contrast, the mRNA and total protein levels of CREB1 were decreased by NTG and increased by VP ( fig. 4A,C) , whereas STAT1 did not change obviously at the transcriptional or translational level ( fig. 4B,C) . Results in this section suggest that the NTG administration activated PKC downstream signalling.
Discussion
Migraine is a highly prevalent neurological disorder with throbbing and unilateral headache. We induced a migraine mouse model via intraperitoneal injection of NTG, a nitric oxide donor. Four hours later, the mice showed head discomforts, including shaking head and scratching with paws, in accordance with the level of nitric oxide in serum. At the same time, the reaction time of mice to cold or hot stimulation was decreased after the application of NTG, most obviously in 4 hr. The expression levels of two pain-related peptides, CGRP and NPY [24, 25] , in serum were increased by NTG. While the mouse head discomforts, the pain threshold decrease and the elevation of CGRP and NPY levels in serum were all attenuated by the VP administration, suggesting that VP played a protective role against migraine-caused neural damage in NTG-injected mice. The elevation of IL-1b and iNOS suggested that NTG induced inflammation in dura mater. In addition, iNOS plays a crucial role in nitric oxide production, so we speculated that the application of exogenous nitric oxide donor induced endogenous nitric oxide production. However, the application of VP reduced the NTGinduced inflammation and nitric oxide production in dura mater.
In addition, nitric oxide-induced migraine is associated with PKC signalling. PKC blockers could reduce the nitric oxide synthesis and decrease nociception [26] . PKC is a family of serine/threonine kinases that contains multiple members. PKC isozymes play vital roles in various signalling, including pain. Sweitzer et al. found already in 2004 that PKCc and e are involved in formalin-induced nociception 2004 [27] . Bhatt et al. [26] demonstrated that the PKCd inhibitor attenuates peptidoglycan-induced expression of iNOS and release of nitric oxide. It has been reported that PKCa and e phosphorylation level is increased in the dorsal root ganglia of rats, following complete Freund adjuvant (CFA)-induced inflammation. What is more important, PKCe involved in the modulatory action of prostaglandin E2 and PKCa play an essential role in purinergic P2X3 receptor-mediated hyperalgesia after inflammation [28, 29] . Based on the above studies, PKCa, c, d and e were selected for assessment with or without NTG or/and VP treatment to investigate the role of PKC signalling in a migraine model. Consistent with previous reports, the phosphorylation level of PKC isozymes was increased after NTG administration, while the total mRNA and protein content was not changed significantly, suggesting that PKC signaling was activated during migraine attack. To confirm this speculation, two downstream substrates, CREB1 and STAT1, were detected.
cAMP-response element binding protein was identified as a nuclear protein binding to the cAMP-response element of somatostatin gene [30] . CREB has been demonstrated to be a crucial transcriptional factor, via binding to promoter region to control multiple genes transcription, involving in neuronal survival, nervous system development, neuroprotection under oxidative stress and disorders of central nervous system, including Alzheimer's disease and Parkinson's disease [31] . CREB is activated via phosphorylation on the Ser133 residue by multiple kinases, including PKC [32] . STAT1 is another transcriptional factor activated by phosphorylation and dimerization. It is well known that STAT1 plays a vital role in interferon (IFN) activation and function. However, IFN-ainduced phosphorylation of STAT1 is abrogated by a dominant-negative form of mutant PKC-d [33] . Moreover, it has been reported that a PKC blocker, calphostin C, inhibited the phosphorylation of CREB and STAT1 [34] . In our study, CREB1 and STAT1 were phosphorylated after the application of NTG, in accordance with PKC isoforms. While the phosphorylation of CREB1, STAT1 and PKC isoforms was reduced by VP treatment, this may be the mechanism by which VP alleviated migraine occurrences and inflammation in dura mater.
Valproate has been approved by FDA for migraine prevention [22] . In our study, the intraperitoneal injection of VP was able to prevent NTG-induced migraine-like discomforts, the decrease in pain threshold and inflammation in dura mater by inhibiting the activation of PKC signalling, which may provide investigational basis for clinical therapy of migraine.
Conclusion
We demonstrated that VP prevented damage due to migraine by inhibiting PKC signalling in NTG-injected mice, which may provide investigational foundation for clinical treatment of migraine.
